Literature DB >> 23415146

Development and preliminary evaluation of the transsexual voice questionnaire for male-to-female transsexuals.

Georgia Dacakis1, Shelagh Davies, Jennifer M Oates, Jacinta M Douglas, Judith R Johnston.   

Abstract

OBJECTIVE: This study reports on the preliminary psychometric evaluation of the Transsexual Voice Questionnaire for Male-to-Female Transsexuals (MtF)-TVQ(MtF), a tool designed to measure the perceptions of MtF transsexuals regarding their voice. The TVQ(MtF) evolved from an extensive review of the existing Transgender Self-evaluation Questionnaire (TSEQ). STUDY
DESIGN: This study was conducted in two phases. In phase I, the TSEQ was reviewed. In phase II, classical test theory was applied to examine two psychometric properties (internal consistency and test-retest reliability) of the TVQ(MtF).
METHOD: In phase I, two speech pathologists and two MtF individuals reviewed the TSEQ, and a comparison was made with the results of a thematic analysis of 137 voice-related extracts from the transcripts of in-depth interviews with 14 MtF individuals. In phase II, 29 Australian and six Canadian MtF transsexuals completed the new tool, the TVQ(MtF) twice with an interim period of 4-6 weeks to enable psychometric evaluation.
RESULTS: Phase I led to substantial changes to the content and structure of the original measure, the TSEQ, and the subsequent development of the TVQ(MtF). In phase II, internal consistency of the TVQ(MtF) was found to be high (time 1 Cronbach's α=.964; time 2 α=.974). Excellent test-retest reliability was demonstrated (intraclass correlation coefficient=0.979; 95% confidence interval=0.968-0.988).
CONCLUSIONS: This study provides psychometric evidence of the reliability of the TVQ(MtF). The MtF participants in this study reported a wide range of vocal functioning and voice-related difficulties. Voice pitch was reported as the most problematic aspect of vocal functioning, and psychosocial issues were the most frequently reported voice-related impacts.
Copyright © 2013 The Voice Foundation. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23415146     DOI: 10.1016/j.jvoice.2012.11.005

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  7 in total

1.  Knowledge, Training, and Attitudes of Students and Speech-Language Pathologists About Providing Communication Services to Individuals Who Are Transgender.

Authors:  Jairus-Joaquin Matthews; Abbie Olszewski; Juli Petereit
Journal:  Am J Speech Lang Pathol       Date:  2020-04-22       Impact factor: 2.408

2.  A Review of Contemporary Assessment Tools for Use with Transgender and Gender Nonconforming Adults.

Authors:  Grant P Shulman; Natalie R Holt; Debra A Hope; Richard Mocarski; Joshua Eyer; Nathan Woodruff
Journal:  Psychol Sex Orientat Gend Divers       Date:  2017-06-15

3.  Voice feminization in male-to-female transgendered clients after Wendler's glottoplasty with vs. without voice therapy support.

Authors:  Juan C Casado; María J Rodríguez-Parra; José A Adrián
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-10       Impact factor: 2.503

4.  Organizing the voice questionnaire for transgender persons.

Authors:  Charlotte Bultynck; Charlotte Pas; Justine Defreyne; Marjan Cosyns; Guy T'Sjoen
Journal:  Int J Transgend Health       Date:  2019-05-08

5.  Examining the voice of Israeli transgender women: Acoustic measures, voice femininity and voice-related quality-of-life.

Authors:  Noa Diamant; Ofer Amir
Journal:  Int J Transgend Health       Date:  2020-08-07

6.  What are the health outcomes of trans and gender diverse young people in Australia? Study protocol for the Trans20 longitudinal cohort study.

Authors:  Michelle Anne Tollit; Carmen C Pace; Michelle Telfer; Monsurul Hoq; Janet Bryson; Nicholas Fulkoski; Charlie Cooper; Ken C Pang
Journal:  BMJ Open       Date:  2019-11-04       Impact factor: 2.692

Review 7.  [Voice diagnostics in phonosurgical interventions].

Authors:  Berit Schneider-Stickler
Journal:  HNO       Date:  2021-05-31       Impact factor: 1.284

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.